A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

NCT01727726 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2182

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder
Depression
Depressive Disorder, Major
Mood Disorders
Mental Disorders

Interventions

DRUG: Brexpiprazole
DRUG: Seroquel XR
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.